Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
Bristol-Myers Squibb
Arun Sanyal; Edgar D Charles; Brent A Neuschwander-Tetri; Rohit Loomba; Stephen A Harrison; Manal F Abdelmalek; Eric J Lawitz; Dina Halegoua-DeMarzio; Sudeep Kundu; Stephanie Noviello; Yi Luo; Rose Christian